Evidence map›Paper›PMID 41734259›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Synergistic Hydrogen-Bonding and Covalent Crosslinking in Polybenzimidazole Membranes for Wide-Temperature Anhydrous Fuel Cells.

Junming Dai, Jianming Zhong, Jinpeng Luo, Yuxing Song, Fan Hu, Young Moo Lee, Yongbing Zhuang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junming DaiState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
Jianming ZhongState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
Jinpeng LuoState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
Yuxing SongState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
Fan HuState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
Young Moo LeeDepartment of Energy Engineering, College of Engineering, Hanyang University, Seoul, Republic of Korea.
Yongbing ZhuangState Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.ORCID https://orcid.org/0000-0003-4577-8142

Funding

Ministry of Science and ICT of Korea GTL24052-100Nano·Materials Technology (YML), Development Program RS-2023-00235295National Natural Science Foundation of China 52173210Project Fund of Jiangsu Bingcheng Hydrogen Energy Technology Co., Ltd
6 · The paper itself

Abstract

Expanding the operational temperature range and reducing the humidity dependence of proton exchange membrane fuel cells (PEMFCs) remain critical challenges. To address these issues, we developed a dual-network architecture that integrates a thermally reinforced hydrogen-bonding matrix with an amine-anhydride covalent crosslinking framework within Tröger's Base (TB)-functionalized polybenzimidazole membranes. The covalently crosslinked TBAm-PBI-TB membrane with dual-network architecture exhibited a high phosphoric acid uptake of 469.5% with negligible leaching and achieved proton conductivities of 255.5 mS cm

Indexed as

dual‐crosslinking networkmembrane electrode assemblyphosphoric acid dopingpolybenzimidazolewide‐temperature‐range proton exchange membrane

Identifiers

PMID41734259
PMCPMC13116360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.